Our QUINT and QUINTx products serve as the foundation of these offerings, ensuring that each solution benefits from a predictive and adaptable framework designed to meet the evolving challenges of antimicrobial resistance.
These tools differentiate Digital Therapeutix with a lean and highly scalable architecture, contrasting traditional resource-heavy approaches. We can bring phage therapy to more people, animals, and communities at lower costs and with faster deployment.